Dawooyinka kansarka awood ay kordhiyaan halista cudurka wadnaha?

Marar dhif ah, daawooyin awood, kaas oo u abaari habka difaaca jirka si ay ula dagaalamaan kansarka, khatar kartaa qalbiga ku jira. Sidaas waxa qoray cilmi.

immunotherapy daroogada Tani. Sanadihii la soo dhaafay, ay gebi ahaanba geedi socodka daaweynta kansarka beddelay, sida bukaanada qaar ka mid ah kuwaas oo ku tiirsan oo keliya hawlgalka bilaabay in dembidhaafka.

The xaaladaha ugu horeysay dhimashada

Si kastaba ha ahaatee, on November 3, ee "New England Journal of Medicine" ayaa sharaxaad ka mid ah laba kiis, marka bukaanada ku jira marxaladaha hore ee melanoma u dhintay cudurka wadnaha laba toddobaad ka dib markii la helo qiyaasta koowaad ee daawooyin sida Opdivo (Nivolumab) iyo Yervoy (Ipilimumab).

Mid ka mid ah bukaannada ku jiray qof dumar ah oo 65-sano jir ah kuwaas oo ka mid ah wadnaha oo shaqadiisa gaba dhintay, halka ka kalena ahaa nin 63-sano jir ah kuwaas oo ku dhintay ka dib markii laba xaaladood oo wadnaha lama filaan ah. Inta lagu guda jiro wadno, dhiigga ku shubma wadnaha ay xiran tahay, taasoo keentay in dhaawac jirka, halka ay dhacdo wadnaha lama filaan ah, waxaa joojiyo wadajir garaaceen.

Halista isticmaalka daroogada oo la mid ah

Warbixinta ayaa sidoo kale intaa ku daray in laba wax soo saarka la mid ah suuqa - Tecentriq (Atezolizumab), daroogada soo wajahay cudurka kansarka kaadiheysta, iyo Keytruda (Pembrolizumab), kaas oo loo isticmaalo daweynta ku faafay melanoma maskaxda ee madaxweynihii hore ee Mareykanka Jimmy Carter - waxaa laga yaabaa in halis la mid ah .

Si kastaba ha ahaatee, xaaladood oo dhaawac wadnaha waa mid aad caadi ahayn, iyo in ka yar 1%. Waxaa la malaysan in halista ugu badan yahay marka labada daroogada waxaa laga qaadaa waqti isku mid ah, ku dar qoraaga warbixinta.

caddayn khabiir

Cilmi baadhayaashu waxay xoogga saaraan in dhibaatooyinka ma detract ka faa'iidooyinka ka mid ah daawooyinka loo isticmaalo dadka qaba kansarka.

"Tani waa a, dhibaato cusub oo horay aan la garanayn daawooyinka nafta lagu badbaadinayo," - yiri qoraaga sare waxbarasho ee, Dr. Javid Moslehi. Isagu waa Agaasimaha oo ka mid ah School of Medicine ee Nashville.

"Waxaan isku dayaynaa in la horumariyo mushkiladda xal loo this. Our shaqo ma aha in la aqoonsado, kuwaas oo daroogo khatar ah, iyo si loo wanaajiyo xaaladda ", - ayaa sheegay in Moslehi.

Daawooyin haddi qofku qaadanayo waa in si taxadar leh loola socdo. Haddii ay ogaatay dhibaatadan cusub, waxaad u baahan doontaa inaad si deg deg ah iyaga siin daawooyinka bedeli jawaabta habka difaaca - cilmi u yidhaahdaan.

Dr. Michael Atkins, agaasime ku-xigeenka Georgetown-Lombardi Comprehensive Xarunta Kansarka ee Washington, DC, ayaa aaminsan in dhibaatooyinka wadnaha uu keeno daawooyinkan, waxa lagu xalin karo. Atkins ahaa mas'uul ka ah daraasadda, inta lagu guda jiro taas oo uu ka labo qof ku dhinteen. "Tani waa dhacdo dhif ah ... laakiin waxay si gaar halis ah", - ayuu yidhi.